Vaxart Appoints Dr. Raquel Bono to Board of Directors

Vaxart, Inc.

Raquel C. Bono, M.D., retired U.S. Navy Vice Admiral, was appointed to Vaxart's board effective Oct. 16, 2026; the board deemed her independent.
Bono led the Defense Health Agency from 2015 to 2019, overseeing a $50 billion global healthcare system serving 9.5 million beneficiaries.
She was appointed under Vaxart's July 2026 cooperation agreement with stockholders and will chair the Stockholder Engagement Committee.
Bono is a Humana (NYSE: HUM) director and served as Chief Health Officer of Viking Cruises (NYSE: VIK) from November 2020 to December 2023.

This headline and bullets were generated automatically by deepseek-v4.1-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.